位置:首页 > 蛋白库 > TTR52_CAEEL
TTR52_CAEEL
ID   TTR52_CAEEL             Reviewed;         135 AA.
AC   G5ED35;
DT   01-MAY-2013, integrated into UniProtKB/Swiss-Prot.
DT   14-DEC-2011, sequence version 1.
DT   03-AUG-2022, entry version 45.
DE   RecName: Full=Transthyretin-like protein 52 {ECO:0000303|PubMed:20526330};
DE   Flags: Precursor;
GN   Name=ttr-52 {ECO:0000312|EMBL:CCO25654.1}; ORFNames=F11F1.7;
OS   Caenorhabditis elegans.
OC   Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC   Rhabditina; Rhabditomorpha; Rhabditoidea; Rhabditidae; Peloderinae;
OC   Caenorhabditis.
OX   NCBI_TaxID=6239;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:ADO60154.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], FUNCTION, SUBCELLULAR LOCATION,
RP   TISSUE SPECIFICITY, INTERACTION WITH CED-1, DISRUPTION PHENOTYPE, AND
RP   MUTAGENESIS OF 11-PHE--PHE-12; VAL-43 AND 50-GLU--LEU-55.
RX   PubMed=20526330; DOI=10.1038/ncb2068;
RA   Wang X., Li W., Zhao D., Liu B., Shi Y., Chen B., Yang H., Guo P., Geng X.,
RA   Shang Z., Peden E., Kage-Nakadai E., Mitani S., Xue D.;
RT   "Caenorhabditis elegans transthyretin-like protein TTR-52 mediates
RT   recognition of apoptotic cells by the CED-1 phagocyte receptor.";
RL   Nat. Cell Biol. 12:655-664(2010).
RN   [2] {ECO:0000312|EMBL:CCO25654.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Bristol N2 {ECO:0000312|EMBL:CCO25654.1};
RX   PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG   The C. elegans sequencing consortium;
RT   "Genome sequence of the nematode C. elegans: a platform for investigating
RT   biology.";
RL   Science 282:2012-2018(1998).
RN   [3] {ECO:0000305}
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=22727702; DOI=10.1016/j.cub.2012.05.052;
RA   Mapes J., Chen Y.Z., Kim A., Mitani S., Kang B.H., Xue D.;
RT   "CED-1, CED-7, and TTR-52 regulate surface phosphatidylserine expression on
RT   apoptotic and phagocytic cells.";
RL   Curr. Biol. 22:1267-1275(2012).
RN   [4] {ECO:0000305}
RP   FUNCTION, AND INTERACTION WITH NRF-5.
RX   PubMed=22727700; DOI=10.1016/j.cub.2012.06.004;
RA   Zhang Y., Wang H., Kage-Nakadai E., Mitani S., Wang X.;
RT   "C. elegans secreted lipid-binding protein NRF-5 mediates PS appearance on
RT   phagocytes for cell corpse engulfment.";
RL   Curr. Biol. 22:1276-1284(2012).
RN   [5] {ECO:0000305, ECO:0000312|PDB:3UAF}
RP   X-RAY CRYSTALLOGRAPHY (2.01 ANGSTROMS) OF 21-135 OF MUTANT 50-GLU--LEU-55,
RP   INTERACTION WITH CED-1, HOMODIMERIZATION, SUBCELLULAR LOCATION, DISRUPTION
RP   PHENOTYPE, AND MUTAGENESIS OF ASP-36; GLU-38; ASP-51; LEU-53; PRO-54;
RP   LEU-55; ARG-63; TRP-65; GLN-73; ASP-80; PRO-83; ASN-85; ARG-100; ASP-101;
RP   ILE-113; LEU-132 AND 131-TYR--TYR-135.
RX   PubMed=22713871; DOI=10.1101/gad.187815.112;
RA   Kang Y., Zhao D., Liang H., Liu B., Zhang Y., Liu Q., Wang X., Liu Y.;
RT   "Structural study of TTR-52 reveals the mechanism by which a bridging
RT   molecule mediates apoptotic cell engulfment.";
RL   Genes Dev. 26:1339-1350(2012).
CC   -!- FUNCTION: Plays a role as a bridging molecule that mediates recognition
CC       and engulfment of apoptotic cells by cross-linking the surface-exposed
CC       phosphatidylserine with the extracellular domain of the phagocyte
CC       receptor ced-1. Important for the generation of extracellular
CC       phosphatidylserine vesicles that promote loss of the exoplasmic leaflet
CC       from apoptotic cells in a time-dependent manner. Required for the
CC       exposure of exoplasmic leaflet on the phagocytic cells surrounding the
CC       apoptotic cells. Does not affect the phosphatidylserine externalization
CC       in living cells. May play a role in mediating transfer of
CC       phosphatidylserine from phosphatidylserine vesicles to ced-1 bearing
CC       phagocytes or alternatively result in the activation of a
CC       phosphatidylserine transporter in the phagocyte that promotes
CC       phosphatidylserine externalization. {ECO:0000269|PubMed:20526330,
CC       ECO:0000269|PubMed:22727700, ECO:0000269|PubMed:22727702}.
CC   -!- SUBUNIT: Homodimer. Interacts with ced-1. Interacts with nrf-5.
CC       {ECO:0000269|PubMed:20526330, ECO:0000269|PubMed:22713871,
CC       ECO:0000269|PubMed:22727700}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:20526330,
CC       ECO:0000269|PubMed:22713871, ECO:0000269|PubMed:22727702}. Cell surface
CC       {ECO:0000269|PubMed:20526330, ECO:0000269|PubMed:22713871,
CC       ECO:0000269|PubMed:22727702}. Note=Detected almost exclusively on the
CC       surface of apoptotic cells. In some embryos, also observed on surface
CC       of cells adjacent to dying cells. {ECO:0000269|PubMed:20526330,
CC       ECO:0000269|PubMed:22713871, ECO:0000269|PubMed:22727702}.
CC   -!- TISSUE SPECIFICITY: Expressed in the intestine cells.
CC       {ECO:0000269|PubMed:20526330}.
CC   -!- DISRUPTION PHENOTYPE: Loses ability to bind apoptotic cells and results
CC       in reduced ability of cell corpse engulfment.
CC       {ECO:0000269|PubMed:20526330, ECO:0000269|PubMed:22713871}.
CC   -!- SIMILARITY: Belongs to the nematode transthyretin-like family.
CC       {ECO:0000255}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; HM130527; ADO60153.1; -; mRNA.
DR   EMBL; HM130528; ADO60154.1; -; Genomic_DNA.
DR   EMBL; Z81059; CCO25654.1; -; Genomic_DNA.
DR   RefSeq; NP_001263732.1; NM_001276803.1.
DR   PDB; 3UAF; X-ray; 2.01 A; A=21-135.
DR   PDBsum; 3UAF; -.
DR   AlphaFoldDB; G5ED35; -.
DR   SMR; G5ED35; -.
DR   STRING; 6239.F11F1.7; -.
DR   PaxDb; G5ED35; -.
DR   EnsemblMetazoa; F11F1.7.1; F11F1.7.1; WBGene00008719.
DR   GeneID; 184363; -.
DR   CTD; 184363; -.
DR   WormBase; F11F1.7; CE47922; WBGene00008719; ttr-52.
DR   eggNOG; ENOG502SV2S; Eukaryota.
DR   HOGENOM; CLU_134800_0_0_1; -.
DR   InParanoid; G5ED35; -.
DR   OMA; DFGPFNT; -.
DR   OrthoDB; 1575315at2759; -.
DR   PRO; PR:G5ED35; -.
DR   Proteomes; UP000001940; Chromosome III.
DR   Bgee; WBGene00008719; Expressed in pharyngeal muscle cell (C elegans) and 3 other tissues.
DR   GO; GO:0009986; C:cell surface; IDA:WormBase.
DR   GO; GO:1903561; C:extracellular vesicle; IDA:WormBase.
DR   GO; GO:0001786; F:phosphatidylserine binding; IDA:WormBase.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:WormBase.
DR   GO; GO:0030674; F:protein-macromolecule adaptor activity; IPI:WormBase.
DR   GO; GO:0005124; F:scavenger receptor binding; IPI:WormBase.
DR   GO; GO:0015917; P:aminophospholipid transport; IMP:WormBase.
DR   GO; GO:1902742; P:apoptotic process involved in development; IMP:UniProtKB.
DR   GO; GO:0043654; P:recognition of apoptotic cell; IDA:WormBase.
DR   Gene3D; 2.60.40.3330; -; 1.
DR   InterPro; IPR001534; Transthyretin-like.
DR   InterPro; IPR038479; Transthyretin-like_sf.
DR   PANTHER; PTHR21700; PTHR21700; 1.
DR   Pfam; PF01060; TTR-52; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Apoptosis; Reference proteome; Secreted; Signal.
FT   SIGNAL          1..20
FT                   /evidence="ECO:0000269|PubMed:20526330"
FT   CHAIN           21..135
FT                   /note="Transthyretin-like protein 52"
FT                   /evidence="ECO:0000269|PubMed:20526330"
FT                   /id="PRO_0000422246"
FT   REGION          131..135
FT                   /note="Required for mediating binding of apoptotic cells by
FT                   ced-1"
FT                   /evidence="ECO:0000269|PubMed:22713871"
FT   MUTAGEN         11..12
FT                   /note="FF->DD: Loss of cell corpse engulfment function."
FT                   /evidence="ECO:0000269|PubMed:20526330"
FT   MUTAGEN         36
FT                   /note="D->A: Partial loss in ability to recognize apoptotic
FT                   cells. Partial rescue of engulfment defect of the deletion
FT                   mutant tm2078. Retains phosphatidylserine binding
FT                   specificity; when associated with A-38."
FT                   /evidence="ECO:0000269|PubMed:22713871"
FT   MUTAGEN         38
FT                   /note="E->A: Partial loss in ability to recognize apoptotic
FT                   cells. Partial rescue of engulfment defect of the deletion
FT                   mutant tm2078. Retains phosphatidylserine binding
FT                   specificity; when associated with A-36."
FT                   /evidence="ECO:0000269|PubMed:22713871"
FT   MUTAGEN         43
FT                   /note="V->M: In sm211; results in increased number of cell
FT                   corpses and abolishes secretion of the protein."
FT                   /evidence="ECO:0000269|PubMed:20526330"
FT   MUTAGEN         50..55
FT                   /note="EDSLPL->AAAAA: In M5; Loss of binding to
FT                   phosphatidylserine and loss of ability to bind apoptotic
FT                   cells and rescue the engulfment defect in the sm211 mutant
FT                   phenotype."
FT                   /evidence="ECO:0000269|PubMed:20526330"
FT   MUTAGEN         51
FT                   /note="D->A: Loss of function of engulfment of apoptotic
FT                   cells. Decreased membrane labeling and phosphatidylserine
FT                   binding and failure to rescue the engulfment defect of the
FT                   deletion mutant tm2078."
FT                   /evidence="ECO:0000269|PubMed:22713871"
FT   MUTAGEN         53
FT                   /note="L->A: Reduced ability in identification of apoptotic
FT                   cells but can rescue the engulfment defect of the deletion
FT                   mutant tm2078."
FT                   /evidence="ECO:0000269|PubMed:22713871"
FT   MUTAGEN         54
FT                   /note="P->A: Reduced ability in identification of apoptotic
FT                   cells but can partially rescue the engulfment defect of the
FT                   deletion mutant tm2078."
FT                   /evidence="ECO:0000269|PubMed:22713871"
FT   MUTAGEN         55
FT                   /note="L->A: Reduced ability in identification of apoptotic
FT                   cells but can rescue the engulfment defect of the deletion
FT                   mutant tm2078."
FT                   /evidence="ECO:0000269|PubMed:22713871"
FT   MUTAGEN         63
FT                   /note="R->D: Monomeric with defective clustering of ced-1
FT                   around apoptotic cells in the embryos of the deletion
FT                   mutant tm2078; when associated with Q-65 and A-73."
FT                   /evidence="ECO:0000269|PubMed:22713871"
FT   MUTAGEN         65
FT                   /note="W->Q: Monomeric with defective clustering of ced-1
FT                   around apoptotic cells in the embryos of the deletion
FT                   mutant tm2078; when associated with D-63 and A-73."
FT                   /evidence="ECO:0000269|PubMed:22713871"
FT   MUTAGEN         73
FT                   /note="Q->A: Monomeric with defective clustering of ced-1
FT                   around apoptotic cells in the embryos of the deletion
FT                   mutant tm2078; when associated with D-63 and Q-65."
FT                   /evidence="ECO:0000269|PubMed:22713871"
FT   MUTAGEN         80
FT                   /note="D->A: Loss of function of engulfment of apoptotic
FT                   cells. Decreased membrane labeling and phosphatidylserine
FT                   binding and failure to rescue the engulment defect of the
FT                   deletion mutant tm2078."
FT                   /evidence="ECO:0000269|PubMed:22713871"
FT   MUTAGEN         83
FT                   /note="P->D: Loss of ability to form ring around apoptotic
FT                   cells and abolished ability in cell corpse removal."
FT                   /evidence="ECO:0000269|PubMed:22713871"
FT   MUTAGEN         85
FT                   /note="N->A: Loss of function of engulfment of apoptotic
FT                   cells. Decreased membrane labeling and phosphatidylserine
FT                   binding and failure to rescue the engulfment defect of the
FT                   deletion mutant tm2078."
FT                   /evidence="ECO:0000269|PubMed:22713871"
FT   MUTAGEN         100
FT                   /note="R->A: Partial loss of ability to recognize apoptotic
FT                   cells. Partial rescue of the engulfment defect of the
FT                   deletion mutant tm2078. Retains phosphatidylserine binding
FT                   specificity; when associated with A-101."
FT                   /evidence="ECO:0000269|PubMed:22713871"
FT   MUTAGEN         101
FT                   /note="D->A: Partial loss of ability to recognize apoptotic
FT                   cells. Partial rescue of the engulfment defect of the
FT                   deletion mutant tm2078. Retains phosphatidylserine binding
FT                   specificity; when associated with A-100."
FT                   /evidence="ECO:0000269|PubMed:22713871"
FT   MUTAGEN         113
FT                   /note="I->R: Fails to rescue the decreased clustering of
FT                   ced-1 around apoptotic cells in the embryos of the deletion
FT                   mutant tm2078; when associated with K-132."
FT                   /evidence="ECO:0000269|PubMed:22713871"
FT   MUTAGEN         131..135
FT                   /note="Missing: Fails to rescue decreased clustering of
FT                   ced-1 around apoptotic cells in the embryos of the deletion
FT                   mutant tm2078."
FT                   /evidence="ECO:0000269|PubMed:22713871"
FT   MUTAGEN         132
FT                   /note="L->K: Fails to rescue decreased clustering of ced-1
FT                   around apoptotic cells in the embryos of the deletion
FT                   mutant tm2078; when associated with R-113."
FT                   /evidence="ECO:0000269|PubMed:22713871"
FT   STRAND          23..32
FT                   /evidence="ECO:0007829|PDB:3UAF"
FT   HELIX           37..40
FT                   /evidence="ECO:0007829|PDB:3UAF"
FT   STRAND          44..49
FT                   /evidence="ECO:0007829|PDB:3UAF"
FT   HELIX           50..54
FT                   /evidence="ECO:0007829|PDB:3UAF"
FT   STRAND          60..65
FT                   /evidence="ECO:0007829|PDB:3UAF"
FT   STRAND          70..78
FT                   /evidence="ECO:0007829|PDB:3UAF"
FT   STRAND          89..94
FT                   /evidence="ECO:0007829|PDB:3UAF"
FT   TURN            100..102
FT                   /evidence="ECO:0007829|PDB:3UAF"
FT   STRAND          108..111
FT                   /evidence="ECO:0007829|PDB:3UAF"
FT   STRAND          119..130
FT                   /evidence="ECO:0007829|PDB:3UAF"
FT   HELIX           132..135
FT                   /evidence="ECO:0007829|PDB:3UAF"
SQ   SEQUENCE   135 AA;  15379 MW;  4B4C46FD94AAF55B CRC64;
     MSRFLIYFLP FFIYSGNVLS KTSCLMATGV LKCPTDPEAV KKVHIDLWDE DSLPLESDDL
     MGRTWSDRNG NFQVTGCASD FGPINTPDPY LYIQHNCPHR DSNATNPIQI DVIPLFLPSI
     VRLGNVYLDR YLEDY
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024